Life Science (UK) Buy Hold or Sell Recommendation
LABS Stock | 34.70 0.20 0.57% |
Assuming the 90 days trading horizon and your complete indifference towards market risk, our recommendation regarding Life Science REIT is 'Strong Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Life Science REIT given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Life Science REIT, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Life Science Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Life and provide practical buy, sell, or hold advice based on investors' constraints. Life Science REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Life |
Execute Life Science Buy or Sell Advice
The Life recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Life Science REIT. Macroaxis does not own or have any residual interests in Life Science REIT or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Life Science's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Life Science Trading Alerts and Improvement Suggestions
Life Science REIT generated a negative expected return over the last 90 days | |
Life Science REIT has high likelihood to experience some financial distress in the next 2 years | |
The company reported the revenue of 19.94 M. Net Loss for the year was (21.71 M) with profit before overhead, payroll, taxes, and interest of 1.28 M. | |
About 70.0% of the company shares are owned by institutional investors |
Life Science Returns Distribution Density
The distribution of Life Science's historical returns is an attempt to chart the uncertainty of Life Science's future price movements. The chart of the probability distribution of Life Science daily returns describes the distribution of returns around its average expected value. We use Life Science REIT price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Life Science returns is essential to provide solid investment advice for Life Science.
Mean Return | -0.17 | Value At Risk | -3.53 | Potential Upside | 2.43 | Standard Deviation | 1.63 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Life Science historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Life Science Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Life Science or Diversified REITs sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Life Science's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Life stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.18 | |
β | Beta against Dow Jones | 0.03 | |
σ | Overall volatility | 1.64 | |
Ir | Information ratio | -0.12 |
Life Science Volatility Alert
Life Science REIT exhibits very low volatility with skewness of -0.71 and kurtosis of 1.19. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Life Science's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Life Science's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Life Science Fundamentals Vs Peers
Comparing Life Science's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Life Science's direct or indirect competition across all of the common fundamentals between Life Science and the related equities. This way, we can detect undervalued stocks with similar characteristics as Life Science or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Life Science's fundamental indicators could also be used in its relative valuation, which is a method of valuing Life Science by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Life Science to competition |
Fundamentals | Life Science | Peer Average |
Return On Equity | -0.14 | -0.31 |
Return On Asset | 0.014 | -0.14 |
Profit Margin | (1.99) % | (1.27) % |
Operating Margin | 0.50 % | (5.51) % |
Current Valuation | 232.99 M | 16.62 B |
Shares Outstanding | 350 M | 571.82 M |
Shares Owned By Insiders | 9.39 % | 10.09 % |
Shares Owned By Institutions | 70.33 % | 39.21 % |
Price To Book | 0.46 X | 9.51 X |
Price To Sales | 6.38 X | 11.42 X |
Revenue | 19.94 M | 9.43 B |
Gross Profit | 1.28 M | 27.38 B |
EBITDA | 8.72 M | 3.9 B |
Net Income | (21.71 M) | 570.98 M |
Total Debt | 107.92 M | 5.32 B |
Book Value Per Share | 0.76 X | 1.93 K |
Cash Flow From Operations | 7.62 M | 971.22 M |
Earnings Per Share | (0.11) X | 3.12 X |
Target Price | 52.33 | |
Beta | 0.019 | -0.15 |
Market Capitalization | 128.45 M | 19.03 B |
Total Asset | 410.7 M | 29.47 B |
Retained Earnings | (41.58 M) | 9.33 B |
Annual Yield | 0.05 % | |
Net Asset | 410.7 M | |
Last Dividend Paid | 0.02 |
Life Science Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Life . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 26308.27 | |||
Daily Balance Of Power | (0.33) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 34.8 | |||
Day Typical Price | 34.77 | |||
Price Action Indicator | (0.20) | |||
Period Momentum Indicator | (0.20) | |||
Relative Strength Index | 39.33 |
About Life Science Buy or Sell Advice
When is the right time to buy or sell Life Science REIT? Buying financial instruments such as Life Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Life Science in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Music and Video Thematic Idea Now
Music and Video
Companies specializing in music, video and movie production and distribution. The Music and Video theme has 10 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Music and Video Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for Life Stock Analysis
When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.